NEOGENNeogen Chemicals Limited
Convert to ideaChemicals & Petrochemicals · Specialty Chemicals · CRISIL: A- (Negative)
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeUp 2.7 this quarter.
Momentum from moving averages, Supertrend and RSI.
8 forensic issues found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
8 found · risk elevated
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹296 Cr | ₹8 Cr | 12.35% | 2.78% | ₹2.96 | 1.5x |
| Q1 FY2027 | ₹250 Cr | ₹17 Cr | 15.99% | 6.84% | ₹6.29 | 2.1x |
| Q4 FY2026 | ₹247 Cr | ₹11 Cr | 14.74% | 4.62% | ₹4.32 | 1.7x |
| Q3 FY2026 | ₹220 Cr | ₹4 Cr | 11.39% | 1.68% | ₹1.40 | 1.3x |
| Q2 FY2026 | ₹209 Cr | ₹3 Cr | 10.85% | 1.62% | ₹1.28 | 1.3x |
| Q1 FY2026 | ₹187 Cr | ₹10 Cr | 13.78% | 5.49% | ₹3.89 | 2.1x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Specialty Chemicals
Compare with peers →Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, specialty polymers, vapor absorption chillers, emerging battery material applications, and other industries. The company also exports its products to 33 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.
Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.